Nanoscale biogenic iron oxides and neurodegenerative disease

High-field magnetic resonance imaging of brain iron: birth of a biomarker?

The brain has an unusually high concentration of iron, which is distributed in an unusual pattern unlike that in any other organ. The physiological role of this iron and the reasons for this pattern of distribution are not yet understood. There is increasing evidence that several neurodegenerative diseases are associated with altered brain iron metabolism. Understanding these dysmetabolic conditions may provide important information for their diagnosis and treatment. For many years the iron distribution in the human brain could be studied effectively only under postmortem conditions. This situation was changed dramatically by the finding that T2-weighted MR imaging at high field strength (initially 1.5 T) appears to demonstrate the pattern of iron distribution in normal brains and that this imaging technique can detect changes in brain iron concentrations associated with disease states. Up to the present time this imaging capability has been utilized in many research applications but it has not yet been widely applied in the routine diagnosis and management of neurodegenerative disorders. However, recent advances in the basic science of brain iron metabolism, the clinical understanding of neurodegenerative diseases and in MRI technology, particularly in the availability of clinical scanners operating at the higher field strength of 3 T, suggest that iron-dependent MR imaging may soon provide biomarkers capable of characterizing the presence and progression of important neurological disorders. Such biomarkers may be of crucial assistance in the development and utilization of effective new therapies for Alzheimer's and Parkinson's diseases, multiple sclerosis and other iron-related CNS disorders which are difficult to diagnose and treat.

Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin

Structures of core nanocrystals of physiological (horse spleen, human liver, and brain) and pathological human brain of patients with progressive supranuclear palsy (PSP) and Alzheimer's disease (AD) ferritin molecules were determined using electron nanodiffraction and high-resolution transmission electron microscopy. The poly-phasic structure of the ferritin cores is confirmed. There are significant differences in the mineral composition between the physiological and pathological ferritins. The physiological ferritin cores mainly consist of single nanocrystals containing hexagonal ferrihydrite (Fh) and hematite (Hm) and some cubic magnetite/maghemite phase. In the pathological cores, Fh is present but only as a minor phase and Hm is absent. The major phases are a face-centered-cubic (fcc) structure with a = 0.43 nm and a high degree of disorder, related to wustite, and a cubic magnetite-like structure. These two cubic phases are also present in human aged normal brain. Evidence for the presence of hemosiderin together with ferritin in the pathological brains is deduced from the similarities of the diffraction patterns with those from patients with primary hemochromatosis, and differences in the shapes and protein composition of the protein shell. These findings suggest a disfunction of the ferritin associated with PSP and AD, associated with an increase in the concentration of brain ferrous toxic iron.

Applications of electron nanodiffraction

Diffraction patterns from regions 1 nm or less in diameter may be recorded in scanning transmission electron microscopy instruments, and have been applied to the investigation of the structures of various nanoparticles, including catalysts, ferrihydrite and ferritins. Applications to nanotubes and related materials and near-amorphous thin films are reported. The coherence of the incident beams may be exploited in studies of crystals and their defects. Several schemes are outlined whereby the information from sequences of nanodiffraction patterns may be combined to provide ultra-high resolution in electron microscope imaging.

Magnetic material arrangement in oriented termites: a magnetic resonance study

Temperature dependence of the magnetic resonance is used to study the magnetic material in oriented Neocapritermes opacus (N.o.) termite, the only prey of the migratory ant Pachycondyla marginata (P.m.). A broad line in the g = 2 region, associated to isolated nanoparticles shows that at least 97% of the magnetic material is in the termite's body (abdomen + thorax). From the temperature dependence of the resonant field and from the spectral linewidths, we estimate the existence of magnetic nanoparticles 18.5+/-0.3 nm in diameter and an effective magnetic anisotropy constant, K(eff) between 2.1 and 3.2 x 10(4)erg/cm(3). A sudden change in the double integrated spectra at about 100K for N.o. with the long body axis oriented perpendicular to the magnetic field can be attributed to the Verwey transition, and suggests an organized film-like particle system.

Magnetic Iron Compounds in Neurological Disorders

Although iron plays an important role in many aspects of human neurophysiology, it also can be toxic under certain circumstances. Anomalous amounts of iron are known to be associated with most types of neurodegenerative disorders such as Alzheimer's, Parkinson's, and Huntington's diseases. To date, little is known about the specific iron compounds present in this tissue and there is recent evidence to suggest that some forms are magnetic. This raises important questions with regard to the role of magnetic iron compounds in disease initiation and progression and, indeed, the origin of these compounds. This paper reviews recent work on the identification and analysis of magnetic iron compounds associated with neurological disorders.

Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue

Elevated iron levels are associated with many types of neurodegenerative disease, such as Alzheimer's, Parkinson's and Huntington's diseases. However, these elevated iron levels do not necessarily correlate with elevated levels of the iron storage or transport proteins, ferritin and transferrin. As such, little is known about the form of this excess iron. It has recently been proposed that some of the excess iron in neurodegenerative tissue may be in the form of the magnetic iron oxide magnetite (Fe(3)O(4)). We demonstrate, for the first time to our knowledge, using highly sensitive superconducting quantum interference device (SQUID) magnetometry, that the concentrations of magnetite are found to be significantly higher in three samples of Alzheimer's disease tissue than in three age- and sex-matched controls. These results have implications, not only for disease progression, but also for possible early diagnosis.

Detection limits for ferrimagnetic particle concentrations using magnetic resonance imaging based proton transverse relaxation rate measurements

A clinical magnetic resonance imaging (MRI) system was used to measure proton transverse relaxation rates (R2) in agar gels with varying concentrations of ferrimagnetic iron oxide nanoparticles in a field strength of 1.5 T. The nanoparticles were prepared by coprecipitation of ferric and ferrous ions in the presence of either dextran or polyvinyl alcohol. The method of preparation resulted in loosely packed clusters (dextran) or branched chains (polyvinyl alcohol) of particles containing of the order of 600 and 400 particles, respectively. For both methods of particle preparation, concentrations of ferrimagnetic iron in agar gel less than 0.01 mg ml(-1) had no measurable effect on the value of R2 for the gel. The results indicate that MRI-based R2 measurements using 1.5 T clinical scanners are not quite sensitive enough to detect the very low concentrations of nanoparticulate biogenic magnetite reported in human brain tissue.

Brain iron metabolism and neurodegenerative disorders

Iron, an essential element for central nervous system (CNS) function, has frequently been found to accumulate in brain regions that undergo degeneration in neurological diseases such as Alzheimer disease, Parkinson disease, Friedreich ataxia and other disorders. However, the precise role of iron in the cause of many neurodegenerative diseases is unclear. To assist in understanding the potential importance of iron in CNS disease, this review summarizes the present knowledge in the areas of CNS iron metabolism, homeostasis and disregulation of iron balance caused by mutations in genes encoding proteins involved in iron transport, storage and metabolism. This review encompasses neurodegenerative disorders associated with both iron overload and deficiency to highlight areas where iron misregulation is likely to be important in the pathophysiology of several human brain diseases.